Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED


YILMAZ S., Karakayali O., Kale E., Akdogan A.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.36, no.3, pp.435-441, 2018 (SCI-Expanded) identifier identifier identifier

Abstract

Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.